FDA Adverse Event Injury Summary report: N

SUMMIT POR TAPER SZ4 HI OFF

MDR report key: 2943894 · Received February 5, 2013

Report

Report Number
1818910-2013-01421
Event Type
Injury
Date Received
February 5, 2013
Date of Event
August 16, 2012
Report Date
January 14, 2013
Manufacturer
DEPUY WARSAW
Product Code
LPH
PMA / PMN Number
K001991
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

THE DEVICES ASSOCIATED WITH THIS REPORT WERE NOT RETURNED. A SEARCH OF THE COMPLAINT DATABASE FOUND NO ADDITIONAL REPORTS FOR THE REPORTED PART AND LOT CODE COMBINATIONS. THE INVESTIGATION COULD NOT VERIFY OR IDENTIFY ANY PRODUCT CONTRIBUTION TO THE REPORTED EVENT WITH THE INFORMATION PROVIDED. BASED ON THE INABILITY TO DETERMINE A ROOT CAUSE, THE NEED FOR CORRECTIVE ACTION WAS NOT INDICATED. DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD ANY ADDITIONAL INFORMATION BE RECEIVED TO CHANGE THE OUTCOME OF THE PERFORMED INVESTIGATION, THE COMPLAINT WILL BE RE-OPENED.

Additional Manufacturer Narrative · 1

THE INVESTIGATION IS ONGOING. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.

Description of Event or Problem · 1

LITIGATION ALLEGES THAT PATIENT EXPERIENCED PAIN, DISCOMFORT, AND INFLAMMATION IN THIGH AND GROIN. SHE ALSO EXPERIENCED A POPPING AND SNAPPING SENSATION IN HER HIP WHEN WALKING OR MOVING TO AND FROM A SITTING POSITION. UPDATE: (B)(4) 2013 PFS WAS RECEIVED FROM LEGAL, MEDICAL RECORDS WERE RECEIVED FROM LEGAL, AND PART/LOT INFORMATION WAS IDENTIFIED. ALTHOUGH LITIGATION REPORTED THIS AS METAL ON METAL, PRODUCT INFORMATION INDICATES THE PATIENT HAD POLY ON METAL. RECORDS INDICATE THAT THE PATIENT WAS REVISED BECAUSE THE STEM WAS GROSSLY LOOSE AND SUBSIDED. RECORDS ARE AVAILABLE FOR FURTHER REVIEW.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
47892 SUMMIT POR TAPER SZ4 HI OFF TOTAL HIP REPLACEMENT LPH DEPUY WARSAW EX4AR1

Patients

Seq Age Sex Outcome Treatment
1 66 YR Required Intervention